Try the political quiz

Candidates  ›  Policies  ›  Domestic Policy

Conservative2019 Prime Minister

Andrew Scheer

Canadian politician.

Overview Policies Discuss Ratings Themes Ideology

Andrew Scheer’s policy on government surveillance

These issues below are sorted in descending order based on how important the average Canadian voter ranked them on the quiz.

Filters

Topics

Should the government be able to monitor phone calls and emails?

  Party’s support baseNo, and enact legislation preventing government surveillance of citizen communications

Andrew Scheer’s answer is based on the following data:

Personal answer

This candidate has not responded to our request to answer this question yet. Help us get it faster by telling them to answer the iSideWith quiz.

Voting record

We are currently researching this candidate’s voting record on this issue. Suggest a link to their voting record on this issue.

Donor influence

We are currently researching campaign finance records for donations that would influence this candidate’s position on this issue. Suggest a link that documents their donor influence on this issue.

Public statements

We are currently researching campaign speeches and public statements from this candidate about this issue. Suggest a link to one of their recent quotes about this issue.

Candidate’s support base

Not enough data to provide a reliable answer yet.

Party influence

We are currently researching this candidate’s political party and its stance on this issue.

Updated 6hrs ago

Party’s support base

Conservative Party Voters’ Answer: No, and enact legislation preventing government surveillance of citizen communications

Importance: More Important

Reference: Analysis of answers from 500 voters that identify as Conservative.

See any errors? Suggest corrections to this candidate’s stance here


Popular conversations

Join in on the post popular conversations.

 @ISIDEWITH submitted…1 day1D

Mexico Slams U.S. Policies as Trump Renews Border War

President Claudia Sheinbaum suggested Tuesday that Mexico could retaliate with tariffs of its own, after U.S. President-elect Donald Trump threatened to impose 25% import duties on Mexican goods if the country doesn’t stop the flow of drugs and migrants across the border.Sheinbaum said she was willing to engage in talks on the issues, but said drugs were a U.S. problem.“One tariff would be followed by another in response, and so on until we put at risk common businesses,” Sheinbaum said, referring to U.S. automakers that have plants on both sides of the border.She said Tuesday that Mexico had done a lot to stem the flow of migrants, noting “caravans of migrants no longer reach the border.” However, Mexico’s efforts to fight drugs like the deadly synthetic opioid fentanyl — which is manufactured by Mexican cartels using chemicals imported from China — have weakened in the last year.Sheinbaum said Mexico suffered from an influx of weapons smuggled in from the United States, and said the flow of drugs “is a problem of public health and consumption in your country’s society.”Sheinbaum also criticized U.S. spending on weapons, saying the money should instead be spent regionally to address the problem of migration. “If a percentage of what the United States spends on war were dedicated to peace and development, that would address the underlying causes of migration,” she said.Sheinbaum’s bristly response suggests that Trump faces a much different Mexican president than he did in his first term.Back in late 2018, former President Andrés Manuel López Obrador was a charismatic, old-school politician who developed a chummy relationship with Trump. The two were eventually able to strike a bargain in which Mexico helped keep migrants away from the border — and received other countries’ deported migrants — and Trump backed down on the threats.

▲  1613 replies

 @ISIDEWITH submitted…1 day1D

Netanyahu Shifts Focus to Iran After Cease-Fire with Hezbollah

Israel approved a cease-fire with Lebanon that is intended to bring a halt to more than a year of fighting with the Hezbollah militia and could help defuse a broader regional crisis that has threatened to ensnare the U.S. and other world powers.“I have some good news to report from the Middle East,” President Biden said on Tuesday, announcing a cease-fire that he said would begin at 4 a.m. local time on Wednesday.Israeli Prime Minister Benjamin Netanyahu backed the agreement earlier in the day, saying it would let Israel focus on the threat from Iran, allow the Israeli military to rest and rearm, and isolate Hamas.“The continuation of the cease-fire will be dependent on what happens in Lebanon. We will enforce the agreement and respond forcefully to every violation,” Netanyahu said.Lebanon’s prime minister, Najib Mikati, welcomed the agreement, saying it would bring “calm and stability in Lebanon and the return of the displaced to their homes and cities.”The Lebanese cabinet is expected to meet on Wednesday to approve steps to enforce the cease-fire, including sending government security forces to areas of southern Lebanon near the border with Israel.Hezbollah has indicated openness to a deal in recent days. “What concerns us are Lebanese national measures and the protection of sovereignty,” Hassan Fadlallah, a member of Parliament affiliated with the group, told The Wall Street Journal on Tuesday.The announcements came after a day of heavy bombardment of Beirut while Israeli ground forces advanced deeper into Lebanese territory. Minutes after Biden spoke, a series of explosions thundered in Beirut. Northern Israel also came under renewed rocket fire.There was no immediate public comment from Hezbollah on the announced cease-fire.If implemented, the agreement would be a diplomatic success for Biden in the twilight of his administration, after more than a year in which the White House has tried to fend off the possibility of a wider regional war. It could also change the landscape that President-elect Donald Trump will face when he takes office in January.

▲  178 replies

 @ISIDEWITH submitted…1 day1D

Trump Appoints Controversial Covid Critic Bhattacharya To National Institute of Health

President Trump announces the nomination of Dr Bhattacharya to Director of the National Institutes of Health.Bhattacharya has called for shifting the agency’s focus toward funding more innovative research and reducing the influence of some of its longest-serving career officials, among other ideas.Trump earlier this month selected Kennedy to lead the Department of Health and Human Services, which oversees NIH and other health agencies. Kennedy has played a central role in choosing top health-care staff and deputies for the next administration, including Marty Makary, a Johns Hopkins surgeon and writer whom Trump announced to lead the Food and Drug Administration, and Dave Weldon, an internal medicine physician and former GOP congressman whom Trump selected to run the Centers for Disease Control and Prevention.Bhattacharya emerged as a prominent critic of the federal government’s covid-19 response, co-writing an October 2020 open letter known as the Great Barrington Declaration that called for rolling back coronavirus-related shutdowns while keeping “focused protections” for vulnerable populations, such as older Americans. The proposal won support from Republican politicians and some Americans eager to resume daily life but was rebuked by public health experts, including then-NIH Director Francis S. Collins, as premature and dangerous as the covid-19 virus continued to spread and vaccines were not yet available.Bhattacharya has called for rolling back the power of some of the 27 institutes and centers that constitute NIH, saying that some career civil servants wrongly shaped national policies at the height of the pandemic and did not tolerate dissent. Bhattacharya and other critics have singled out Anthony S. Fauci, the infectious-disease expert who led one of NIH’s centers for 38 years and helped steer the nation’s coronavirus response before leaving the federal government in December 2022.Trump Appoints Controversial Covid Critic Bhattacharya To NIH

▲  188 replies